Rehman Saud, Edmonds Christine E, Mankoff David A, Pantel Austin R, O'Brien Sophia R
From the CUNY School of Medicine, New York, NY.
Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA.
Clin Nucl Med. 2025 Mar 1;50(3):221-223. doi: 10.1097/RLU.0000000000005465. Epub 2024 Oct 10.
A 78-year-old woman diagnosed with left breast invasive lobular carcinoma with left axillary nodal metastasis underwent 18 F-fluoroestradiol (FES) PET/CT imaging for further evaluation of indeterminate right axillary lymph nodes seen on staging 18 F-FDG PET/CT. 18 F-FES PET/CT revealed abnormal 18 F-FES-avid right axillary and bilateral cervical nodes, subsequently biopsy-proven metastases, upstaging the patient from stage II to IV and greatly changing patient management. This case demonstrates the value of 18 F-FES PET/CT in accurately staging metastatic invasive lobular carcinoma at diagnosis, an indication for which 18 F-FES PET/CT "may be appropriate" per current Society of Nuclear Medicine and Molecular Imaging guidelines.
一名78岁女性被诊断为左乳腺浸润性小叶癌伴左腋窝淋巴结转移,因在分期18F-FDG PET/CT上发现右腋窝淋巴结情况不明而接受18F-氟雌二醇(FES)PET/CT成像进一步评估。18F-FES PET/CT显示右腋窝和双侧颈部淋巴结有异常的18F-FES摄取,随后经活检证实为转移灶,从而将该患者的分期从II期提高到IV期,并极大地改变了患者的治疗方案。本病例证明了18F-FES PET/CT在诊断时准确分期转移性浸润性小叶癌方面的价值,根据核医学与分子影像学会目前的指南,18F-FES PET/CT “可能适用” 于这一情况。